Researcher
Kris Verburgh
- Research Expertise:
Dr. Verburgh’s research interests are the aging process (biogerontology), evolutionary medicine, metabolism and nutrition.
He researches diets, foods, nutrients, medications and other interventions that can extend (healthy) lifespan and reduce the risk of aging-related diseases like cardiovascular disease, type 2 diabetes, neurodegenerative diseases (Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, vascular dementia, …), sarcopenia (muscle loss), macular degeneration, osteoporosis, etc.
His specific biogerontological interests are mTOR (mammalian or mechanistic Target of Rapamycin), the insulin/insulin-like growth factor signaling (IIS) pathway, protein agglomeration, amyloidosis, autophagy, mitochondrial dysfunction, advanced glycation endproducts (AGEs), membrane senescence, lysosomal dysfunction, etc.
He examines how insights from the biogerontological field can be used to asses and predict the efficacy of dietary, nutritional or medical interventions aimed at reducing the risk of aging-related diseases and increasing healthy life span.
In addition, Dr. Verburgh has a keen interest in evolution, the origin and complexity of life, and neuroscience (consciousness, neurotheology, neuroesthetics, theory of mind and the origins of creativity) and has written two books on those subjects.
- Keywords:Philosophy (incl. moral science)
- Users of research expertise:
Dr. Verburgh’s research interests are the aging process (biogerontology), evolutionary medicine, metabolism and nutrition.
He researches diets, foods, nutrients, medications and other interventions that can extend (healthy) lifespan and reduce the risk of aging-related diseases like cardiovascular disease, type 2 diabetes, neurodegenerative diseases (Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, vascular dementia, …), sarcopenia (muscle loss), macular degeneration, osteoporosis, etc.
His specific biogerontological interests are mTOR (mammalian or mechanistic Target of Rapamycin), the insulin/insulin-like growth factor signaling (IIS) pathway, protein agglomeration, amyloidosis, autophagy, mitochondrial dysfunction, advanced glycation endproducts (AGEs), membrane senescence, lysosomal dysfunction, etc.
He examines how insights from the biogerontological field can be used to asses and predict the efficacy of dietary, nutritional or medical interventions aimed at reducing the risk of aging-related diseases and increasing healthy life span.
In addition, Dr. Verburgh has a keen interest in evolution, the origin and complexity of life, and neuroscience (consciousness, neurotheology, neuroesthetics, theory of mind and the origins of creativity) and has written two books on those subjects.